Tag: targeted therapy
Savolitinib Shows Promise for MET-Amplified Gastric Cancer in Phase 2 Trial
A phase 2 trial shows promising clinical efficacy for savolitinib in treating patients with MET-amplified gastric or gastroesophageal junction adenocarcinoma.…
Submit Your Paper to GMJ
No APC until January 2027.